TCM
AGN

Tekla Capital Management’s Allergan Inc AGN Stock Holding History

Tekla Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-228,227
Closed -$48.5M – 129
2014
Q4 		$48.5M Hold
228,227
– – 2.27% 14
2014
Q3 		$40.7M Buy
228,227
+71,600
+46% +$11.9M 1.91% 13
2014
Q2 		$26.5M Sell
156,627
-59,710
-28% -$9.3M 2.43% 12
2014
Q1 		$26.8M Buy
216,337
+49,760
+30% +$6.06M 2.68% 12
2013
Q4 		$18.5M Hold
166,577
– – 1.94% 16
2013
Q3 		$15.1M Buy
166,577
+73,500
+79% +$6.6M 1.68% 18
2013
Q2 		$7.84M Buy
+93,077
New +$9.66M 1.07% 27

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Tekla Capital Management's AGN Position: Q1 2015 in Review

Tekla Capital Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 228,227 shares — an estimated $48.5M sold.

Tekla Capital Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $48.5M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Tekla Capital Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Tekla Capital Management sold 228,227 Allergan Inc shares in Q1 2015, an estimated $48.5M.
  • Tekla Capital Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Tekla Capital Management's Allergan Inc position peaked at $48.5M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Tekla Capital Management's 13F filing for Q1 2015, filed 6 May 2015.